Octave Specialty Group, Inc. (OSG) SEC Filings & Earnings Calls
EquiReason read 12 Octave Specialty Group, Inc. SEC filings in the last 12 months. Latest: 10-Q on 2026-08-06 — Octave Specialty Group reported Q2 2026 results with strong revenue growth in Insurance Distribution and Specialty P&C segments, but continued net losses and reduced liquidity..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 214.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
6 Aug 202610-QOctave Specialty Group reported Q2 2026 results with strong revenue growth in Insurance Distribution and Specialty P&C segments, but continued net losses and reduced liquidity.earningsopen
Figures in the filing · each found in the filing text
| Gross premiums written · Specialty Property and Casualty Insurance · Q2-2026 | $94702.00 | -2% y/y |
| Net premiums written · Specialty Property and Casualty Insurance · Q2-2026 | $23142.00 | +52% y/y |
| Net premiums earned · Specialty Property and Casualty Insurance · Q2-2026 | $21749.00 | +34% y/y |
| Commission income · Insurance Distribution · Q2-2026 | $49728.00 | +64% y/y |
| Combined ratio · Specialty Property and Casualty Insurance · Q2-2026 | 100.6% | |
| EBITDA · Insurance Distribution · Q2-2026 | $13887.00 | +196% y/y |
| Total revenues · Q2-2026 | $82995.00 | +51% y/y |
| Net income (loss) attributable to shareholders · Q2-2026 | $-14429.00 | +80% y/y |
Risks flagged
Litigation settlement impact
“The higher loss and loss adjustment expenses for the six months ended June 30, 2026, is due to the growth in our P&C program business and prior period development primarily related to (i) $2,125 of net losses and $5,787 of LAE (legal expenses) from the first quarter 2026 settlement of a potential litigation matter related to an insurance claim” · word for word
Seasonal revenue concentration
“Our ID businesses may experience seasonal impacts on their revenues and net results. For example, our A&H businesses collectively produce the majority of their business in the first quarter of each year resulting in revenue and earnings concentrations in the first quarter.” · word for word
Economic and social inflation impact on loss reserves
“Loss and loss adjustment expenses incurred, and Everspan's associated Loss and LAE ratio, may be adversely impacted by economic and social inflation. The impact of inflation on ultimate loss reserves is difficult to estimate, particularly in light of recent disruptions to the judicial system, supply chains and labor markets.” · word for word
6 Aug 20268-K · 2.02Insurance Distribution revenue grew 77% (44% organic), Adjusted EBITDA nearly quadrupled to $10M; Everspan combined ratio improved >600bps to 61.4%; net loss narrowed to $(14.4)M from $(20.5)M.earningsopen
Figures in the filing · each found in the filing text
| Total revenues · Q2-2026 | $83M | +51% y/y |
| Net income (loss) attributable to shareholders · Q2-2026 | $-14M | |
| Adjusted EBITDA to shareholders · Q2-2026 | $4M | |
| Gross premiums written · Specialty P&C Insurance · Q2-2026 | $95M | -2% y/y |
| Net premiums written · Specialty P&C Insurance · Q2-2026 | $23M | +52% y/y |
| Loss ratio · Specialty P&C Insurance · Q2-2026 | 61.4% | |
| Insurance Distribution revenue · Insurance Distribution · Q2-2026 | $58M | +77% y/y |
| Organic revenue growth · Insurance Distribution · Q2-2026 | 44.0% | |
| Adjusted EBITDA to shareholders (Insurance Distribution) · Insurance Distribution · Q2-2026 | $10M | +233% y/y |
| Adjusted EBITDA to shareholders (Everspan) · Specialty P&C Insurance · Q2-2026 | $2M | +157% y/y |
Risks flagged
Soft property market conditions may pressure future growth in Insurance Distribution.
“against the backdrop of increasingly soft property market conditions” · word for word
Everspan repositioning still in progress; gross premiums written declined 2% Y/Y.
“Gross and net premiums written totaled $95 million and $23 million, down (2)%” · word for word
6 May 202610-QGross premiums written $104M (+19% y/y); Net premiums written $32M (+80% y/y); Net premiums earned $20M (+28% y/y)open
Figures in the filing · each found in the filing text
| Gross premiums written · Specialty P&C · Q1-2026 | $104M | +19% y/y |
| Net premiums written · Specialty P&C · Q1-2026 | $32M | +80% y/y |
| Net premiums earned · Specialty P&C · Q1-2026 | $20M | +28% y/y |
| Commission income · Insurance Distribution · Q1-2026 | $68M | +85% y/y |
| Premiums placed · Insurance Distribution · Q1-2026 | $427M | +83% y/y |
| Loss and LAE ratio · Specialty P&C · Q1-2026 | 98.4% | |
| Combined ratio · Specialty P&C · Q1-2026 | 149.7% | |
| ID segment EBITDA · Insurance Distribution · Q1-2026 | $31M | +155% y/y |
| Net income (loss) attributable to shareholders · Q1-2026 | $-7M | +85% y/y |
Risks flagged
Litigation settlement impact
“$2,125 of net losses and $5,787 of LAE from settlement of a potential litigation matter.” · word for word
Reserve strengthening on excess liability
“Slight reserve strengthening on an excess liability program and claim fees.” · word for word
Economic and social inflation on loss reserves
“The impact of inflation on ultimate loss reserves is difficult to estimate.” · word for word
Dependence on acquisitions for growth
“Acquisitions within the ID segment have had a significant impact on the comparability of results.” · word for word
6 May 20268-K · 2.02Q1 2026 total revenue up 66% YoY to $104M; Insurance Distribution revenue up 92% (42% organic); Adjusted EBITDA to shareholders $20.1M vs -$1.3M prior year; Everspan gross premiums written up 19% to $104M; net loss from litigation settlemenearningsopen
Figures in the filing · each found in the filing text
| Total Revenue · Q1-2026 | $104M | +66% y/y |
| Total P&C Premium Production · Q1-2026 | $531M | +66% y/y |
| Insurance Distribution Revenue · Insurance Distribution · Q1-2026 | $79M | +92% y/y |
| Insurance Distribution Organic Revenue Growth · Insurance Distribution · Q1-2026 | 42.0% | |
| Insurance Distribution Net Income · Insurance Distribution · Q1-2026 | $13M | -533% y/y |
| Insurance Distribution Adjusted EBITDA · Insurance Distribution · Q1-2026 | $25M | +257% y/y |
| Everspan Gross Premiums Written · Specialty P&C Insurance · Q1-2026 | $104M | +19% y/y |
| Everspan Net Premiums Written · Specialty P&C Insurance · Q1-2026 | $32M | +80% y/y |
| Adjusted EBITDA to Shareholders · Q1-2026 | $20M | -1659% y/y |
| Adjusted Net Income to Shareholders · Q1-2026 | $17M | -375% y/y |
Risks flagged
Litigation settlement in Everspan segment caused $2.1M losses and $5.8M LAE, leading to net loss of $(8)M
“The first quarter 2026 net loss was driven primarily by losses and LAE from the settlement of a potential litigation matter related to an insurance claim.” · word for word
Everspan segment still in turnaround; active programs loss ratio 57% but overall segment reported net loss
“Everspan's turnaround is also gaining momentum... our active programs were running at a loss ratio of 57% in the first quarter.” · word for word
10 Apr 2026DEF 14AProxy statement detailing executive compensation, incentive plan design, and governance changes following the sale of the legacy financial guarantee business.open
Figures in the filing · each found in the filing text
| Adjusted EBITDA Margin (after NCI) · Insurance Distribution · FY2025 | 16.0% | |
| Revenue Growth · Insurance Distribution · FY2025 | 65.1% | |
| Everspan Net Combined Ratio · Specialty Property & Casualty Insurance · FY2025 | 105.2% | |
| Adjusted EBITDA to shareholders · Insurance Distribution · FY2025 | $23M | |
| Total Revenues · Insurance Distribution · FY2025 | $164M | |
| Net Income (Loss) · Consolidated · FY2025 | $-96M | |
| Combined Ratio · Everspan · FY2025 | 105.2% | |
| WLACC Net Par Outstanding · Legacy Financial Guarantee · FY2024 | $5.10B | |
| Everspan EBITDA · Everspan · FY2024 | $7M | |
| Xchange EBITDA · Xchange · FY2024 | $22M |
Risks flagged
Key person retention risk
“The Sale Transaction qualified as a “Change in Control” under our existing executive employment agreements, including with three Continuing Officer NEOs (Messrs. LeBlanc and Trick and Ms. Smith), and under our equity plans. Under those arrangements with the applicable Continuing Officer NEOs, executives had the ability to resign for “Good Reason” and receive” · word for word
Compensation clawback risk
“Awards granted pursuant to the 2026 Plan will be subject to mandatory repayment to the Company to the extent the participant is, or in the future becomes, subject to (x) any Company “clawback” or recoupment policy that is adopted, or (y) any law, rule, requirement or regulation which imposes mandatory recoupment.” · word for word
7 Apr 20268-K · 1.01, 2.03OSG entered into a First Amendment to Credit Agreement, obtaining an additional $40M term loan, increasing total term loans to $139.375M, with proceeds to fund put rights of minority shareholders.open
Figures in the filing · each found in the filing text
| Total outstanding term loans · Q2-2026 | $139M |
Risks flagged
Increased leverage to fund minority shareholder put rights may indicate financial strain or governance complexity.
“Proceeds from the Additional Term Loan will be used to fund the payment of Cirrata UK's obligation to honor the put rights exercised in March 2026 by certain minority shareholders.” · word for word
4 Mar 202610-KGross commissions $143M (+56% y/y); Net commissions $106M (+108% y/y); Premiums placed $952M (+93% y/y)open
Figures in the filing · each found in the filing text
| Gross commissions · Insurance Distribution · FY2025 | $143M | +56% y/y |
| Net commissions · Insurance Distribution · FY2025 | $106M | +108% y/y |
| Premiums placed · Insurance Distribution · FY2025 | $952M | +93% y/y |
| Gross written premiums · Specialty P&C Insurance · FY2025 | $360M | -6% y/y |
| Retention rate · Specialty P&C Insurance · FY2025 | 20.5% | |
| Net assets (holding company) · Holding Company · FY2025 | $76M | |
| Net operating loss carry-forwards · Holding Company · FY2025 | $1.70B |
Risks flagged
Reinsurance availability risk
“inability to obtain reinsurance coverage on economic terms” · word for word
Underwriting loss reserve inadequacy
“greater than expected underwriting losses in the Company’s specialty property and casualty insurance business resulting in inadequacy of loss and loss expense reserves” · word for word
Dependence on third-party program partners
“dependence on third parties, including specialty insurance program partners, reinsurers, distribution relationships, and other service providers, and the risk of failures or disruptions in their performance” · word for word
23 Feb 20268-K · 2.02Total P&C Premium Production $303M (+15% y/y); Commission Income $37M (+13% y/y); Organic Revenue Growth 8.1earningsopen
Figures in the filing · each found in the filing text
| Total P&C Premium Production · Q4-2025 | $303M | +15% y/y |
| Commission Income · Insurance Distribution · Q4-2025 | $37M | +13% y/y |
| Organic Revenue Growth · Insurance Distribution · Q4-2025 | 8.1% | |
| Gross Premiums Written · Specialty P&C (Everspan) · Q4-2025 | $80M | +34% y/y |
| Net Premiums Written · Specialty P&C (Everspan) · Q4-2025 | $23M | +978% y/y |
| Combined Ratio · Specialty P&C (Everspan) · Q4-2025 | 100.0% | |
| Total Revenue from Continuing Operations · Q4-2025 | $67M | +3% y/y |
| Net Loss from Continuing Ops to Shareholders · Q4-2025 | $-30M | +35% y/y |
| Adjusted EBITDA to Shareholders · Q4-2025 | $1M | |
| Adjusted Net Loss to Shareholders · Q4-2025 | $-1M | -81% y/y |
Risks flagged
Transaction and restructuring costs pressuring profitability
“The higher net loss was primarily attributed to costs associated with the acquisition of ArmadaCare, expenses associated with the exit from the financial guarantee business, and related expense reduction initiatives, and the impairment of a minority investment from a legacy strategy.” · word for word
Everspan segment revenue decline
“a $1.2 million decline in Adjusted EBITDA at Everspan, associated primarily with Everspan's decline in revenue” · word for word
10 Nov 202510-QAmbac reported mixed Q3 2025 results: strong growth in Insurance Distribution premiums placed (+69.3% YoY) but a decline in Specialty P&C gross premiums written (-15.6% YoY) and a wider consolidated pretax loss.earningsopen
Figures in the filing · each found in the filing text
| Gross Premiums Written - Specialty P&C · Specialty Property & Casualty Insurance · Q3-2025 | $97M | -16% y/y |
| Premiums Placed - Insurance Distribution · Insurance Distribution · Q3-2025 | $245M | +69% y/y |
| Total Revenues · Q3-2025 | $67M | -5% y/y |
| Pretax Income (Loss) · Q3-2025 | $-32M | |
| Adjusted EBITDA Attributable to Ambac Common Stockholders · Q3-2025 | $-3M | |
| Net Income (Loss) Attributable to Ambac Shareholders · Q3-2025 | $-32M |
Risks flagged
Substantial Indebtedness from ArmadaCare Acquisition
“AFG and the Insurance Distribution business have substantial indebtedness, resulting from the acquisition of ArmadaCare on October 31, 2025, which could adversely affect our financial condition, operational flexibility and our ability to obtain financing in the future.” · word for word
Dependence on Limited Number of Capacity Providers
“Our Insurance Distribution businesses derive a significant portion of their commission revenues from a limited number of insurance companies and Lloyd's syndicates, the loss of any of which could result in lower commissions or loss of business production.” · word for word
Goodwill and Intangible Asset Impairment Risk
“Any intangible asset or goodwill impairment could adversely affect the Company's operating results and financial condition.” · word for word
Integration and De Novo Launch Risks
“Acquisitions have been an important contributor of growth in the Insurance Distribution business and we believe that additional acquisitions will be important to future growth... the failure of acquisition targets to achieve anticipated revenue and earnings levels could result in slower than anticipated growth and result in intangible asset or goodwill impai” · word for word
10 Nov 20258-K · 2.02Total revenue from continuing operations $67M (-5% y/y); Net loss from continuing operations attributable to Ambac shareholders $-32M; Total P&C premium production $343M (+32% y/y)earningsopen
Figures in the filing · each found in the filing text
| Total revenue from continuing operations · Q3-2025 | $67M | -5% y/y |
| Net loss from continuing operations attributable to Ambac shareholders · Q3-2025 | $-32M | |
| Total P&C premium production · Q3-2025 | $343M | +32% y/y |
| Insurance Distribution revenue · Insurance Distribution · Q3-2025 | $43M | +80% y/y |
| Adjusted EBITDA to shareholders · Q3-2025 | $-3M |
Risks flagged
Adverse loss experience at Everspan; combined ratios expected to improve only by 2026-2027.
“Adverse loss experience in the quarter unfavorably affected Everspan's results” · word for word
3 Nov 20258-K · 1.01, 2.01, 2.03, 7.01Total Consideration $250Mopen
Figures in the filing · each found in the filing text
| Total Consideration | $250M |
Risks flagged
Integration risk and increased leverage from debt financing.
“$100,000,000 was financed with the Term Loan, $20,000,000 was drawn under the Revolving Facility” · word for word
Octave Specialty Group, Inc. — questions
- What did Octave Specialty Group, Inc. file recently?
- 12 SEC filings in the last 12 months. Latest: 10-Q on 2026-08-06 — Octave Specialty Group reported Q2 2026 results with strong revenue growth in Insurance Distribution and Specialty P&C segments, but continued net losses and reduced liquidity.
Every figure on this page comes from Octave Specialty Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.